---
$id: https://graph.org.ai/products/commodity/51361934
$type: Product
source: UNSPSC
code: "51361934"
title: "Hexobarbital sodium"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hexobarbital sodium

**UNSPSC Code**: 51361934
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C12H15N2O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I788X867K7, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1,5-dimethyl-, monosodium salt but more generally known as hexobarbital sodium, which bears US NIH Compound Identifier 3608. European Medicines Agency schedules Hexobarbital sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02514MIG. Most nations, for tariff and trade purposes, schedule hexobarbital sodium under HS 29335400. As of Q4 2014, HEXOBARBITAL SODIUM remains US FDA's Preferred Term for this commodity. Hexobarbital sodium bears US NLM identifiers UMLS ID C0037514 and NCI Concept Code C72808. SMILES: CC1(C(=O)[N-]C(=O)N(C1=O)C)C2=CCCCC2.[NA+].

